Search Results - "Zeeuwen, P.L.J.M."

  • Showing 1 - 17 results of 17
Refine Results
  1. 1
  2. 2

    The cystatin M / E-controlled pathway of skin barrier formation: expression of its key components in psoriasis and atopic dermatitis by Cheng, T., Tjabringa, G.S., Van Vlijmen-Willems, I.M.J.J., Hitomi, K., Van Erp, P.E.J., Schalkwijk, J., Zeeuwen, P.L.J.M.

    Published in British journal of dermatology (1951) (01-08-2009)
    “…Summary Background  The antiprotease activity of cystatin M/E regulates skin barrier formation, as it inhibits the activity of cathepsin V, cathepsin L and…”
    Get full text
    Journal Article
  3. 3

    CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes by Van Lingen, R.G., Van De Kerkhof, P.C.M., Seyger, M.M.B., De Jong, E.M.G.J., Van Rens, D.W.A., Poll, M.K.P., Zeeuwen, P.L.J.M., Van Erp, P.E.J.

    Published in British journal of dermatology (1951) (01-06-2008)
    “…Summary Background  Psoriasis is known to affect 2–3% of the population and can be considered an organ‐specific autoimmune disease. CD26/dipeptidyl‐peptidase…”
    Get full text
    Journal Article
  4. 4

    Polymorphisms in CD84, IL12B and TNFAIP3 are associated with response to biologics in patients with psoriasis by Reek, J.M.P.A., Coenen, M.J.H., L'Isle Arias, M., Zweegers, J., Rodijk‐Olthuis, D., Schalkwijk, J., Vermeulen, S.H., Joosten, I., Kerkhof, P.C.M., Seyger, M.M.B., Zeeuwen, P.L.J.M., Jong, E.M.G.J.

    Published in British journal of dermatology (1951) (01-05-2017)
    “…Summary Background The effectiveness of biologics for psoriasis shows heterogeneity among patients. With pharmacogenetic markers, it might be possible to…”
    Get full text
    Journal Article
  5. 5

    Mast-cell interleukin-1β, neutrophil interleukin-17 and epidermal antimicrobial proteins in the neutrophilic urticarial dermatosis in Schnitzler's syndrome by de Koning, H.D., van Vlijmen-Willems, I.M.J.J., Rodijk-Olthuis, D., van der Meer, J.W.M., Zeeuwen, P.L.J.M., Simon, A., Schalkwijk, J.

    Published in British journal of dermatology (1951) (01-08-2015)
    “…Summary Background Schnitzler's syndrome (SchS) is an autoinflammatory disease characterized by a chronic urticarial rash, a monoclonal component and signs of…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Molecular diagnostics of psoriasis, atopic dermatitis, allergic contact dermatitis and irritant contact dermatitis by Kamsteeg, M., Jansen, P.A.M., Van Vlijmen-Willems, I.M.J.J., Van Erp, P.E.J., Rodijk-Olthuis, D., Van Der Valk, P.G., Feuth, T., Zeeuwen, P.L.J.M., Schalkwijk, J.

    Published in British journal of dermatology (1951) (01-03-2010)
    “…Summary Background  Microarray studies on the epidermal transcriptome in psoriasis and atopic dermatitis (AD) have revealed genes with disease‐specific…”
    Get full text
    Journal Article
  8. 8

    Paediatric-onset psoriasis is associated with ERAP1 and IL23R loci, LCE3C_LCE3B deletion and HLA-C06 by Bergboer, J.G.M., Oostveen, A.M., de Jager, M.E.A., den Heijer, M., Joosten, I., van de Kerkhof, P.C.M., Zeeuwen, P.L.J.M., de Jong, E.M.G.J., Schalkwijk, J., Seyger, M.M.B.

    Published in British journal of dermatology (1951) (01-10-2012)
    “…Summary Background  Recent genome‐wide association studies have identified several genetic risk factors for psoriasis, but data on their association with age…”
    Get full text
    Journal Article
  9. 9

    The effect of adalimumab on key drivers in the pathogenesis of psoriasis by Hendriks, A.G.M., van der Velden, H.M.J., Wolberink, E.A.W., Seyger, M.M.B., Schalkwijk, J., Zeeuwen, P.L.J.M., de Jong, E.M.G.J., Pasch, M.C., van Erp, P.E.J., van de Kerkhof, P.C.M.

    Published in British journal of dermatology (1951) (01-03-2014)
    “…Summary Background The use of recently introduced biologics targeting specific immune mechanisms has identified crucial steps in the pathogenesis of psoriasis…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Keratolysis exfoliativa (dyshidrosis lamellosa sicca): a distinct peeling entity by Chang, Y.Y., van der Velden, J., van der Wier, G., Kramer, D., Diercks, G.F.H., van Geel, M., Coenraads, P.J., Zeeuwen, P.L.J.M., Jonkman, M.F.

    Published in British journal of dermatology (1951) (01-11-2012)
    “…Summary Background  Keratolysis exfoliativa (KE), also known as dyshidrosis lamellosa sicca, is a palmoplantar dermatosis characterized by air‐filled blisters…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Induction of SLPI (ALP/HUSI-I) in Epidermal Keratinocytes by Wingens, Miriam, van Bergen, Bert H., van Vlijmen-Willems, Ivonne M.J.J., Zeeuwen, Patrick L.J.M., van Ruissen, Fred, Schalkwijk, Joost, Hiemstra, Pieter S., Meis, Jacques F.G.M., Mulder, Janet, Kramps, Hans A.

    Published in Journal of investigative dermatology (01-12-1998)
    “…Secretory leukocyte protease inhibitor (SLPI) is a small, cationic protein that is known to be constitutively expressed by several glandular epithelia. SLPI…”
    Get full text
    Journal Article
  16. 16

    Cystatin M / E expression in inflammatory and neoplastic skin disorders by Zeeuwen, P.L.J.M., Van Vlijmen-Willems, I.M.J.J., Egami, H., Schalkwijk, J.

    Published in British journal of dermatology (1951) (01-07-2002)
    “…Summary Background Cystatins are natural and specific inhibitors of endogenous mammalian lysosomal cysteine proteinases and exogenous microbial cysteine…”
    Get full text
    Journal Article
  17. 17

    Assignment of the human gene encoding the epidermal serine proteinase inhibitor SKALP (PI3) to chromosome region 20q12-->q13 by Molhuizen, H O, Zeeuwen, P L, Olde Weghuis, D, Geurts van Kessel, A, Schalkwijk, J

    Published in Cytogenetics and cell genetics (01-01-1994)
    “…Recently we isolated a cDNA clone corresponding to an epidermal serine proteinase inhibitor named SKALP (skin-derived antileukoproteinase). Here we report the…”
    Get more information
    Journal Article